The Dex-treated rats’ heart proteomes showed an increase in the levels of the enzyme hydroxysteroid 11-beta dehydrogenase 1(HSD11B1), which is known to augment GC action and increase the adverse effects of the drug, leading to increased insulin resistance, dyslipidemia, and hypertension [39]. The gene discussed is INS; the disease is Hypertension.